Cambridge Investment Research Advisors Inc. Boosts Position in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA)

Cambridge Investment Research Advisors Inc. lifted its holdings in shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 4.7% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 18,921 shares of the real estate investment trust’s stock after purchasing an additional 853 shares during the quarter. Cambridge Investment Research Advisors Inc.’s holdings in Sabra Healthcare REIT were worth $331,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently modified their holdings of the business. VSM Wealth Advisory LLC bought a new stake in shares of Sabra Healthcare REIT in the 4th quarter worth approximately $26,000. UMB Bank n.a. grew its holdings in shares of Sabra Healthcare REIT by 379.6% during the 1st quarter. UMB Bank n.a. now owns 2,048 shares of the real estate investment trust’s stock valued at $36,000 after purchasing an additional 1,621 shares during the last quarter. Assetmark Inc. grew its holdings in shares of Sabra Healthcare REIT by 33.4% during the 4th quarter. Assetmark Inc. now owns 2,618 shares of the real estate investment trust’s stock valued at $45,000 after purchasing an additional 656 shares during the last quarter. Fifth Third Bancorp grew its holdings in shares of Sabra Healthcare REIT by 110.3% during the 1st quarter. Fifth Third Bancorp now owns 3,835 shares of the real estate investment trust’s stock valued at $67,000 after purchasing an additional 2,011 shares during the last quarter. Finally, GF Fund Management CO. LTD. bought a new position in shares of Sabra Healthcare REIT during the 4th quarter valued at $74,000. Hedge funds and other institutional investors own 99.40% of the company’s stock.

Insider Transactions at Sabra Healthcare REIT

In related news, Director Michael J. Foster sold 11,000 shares of Sabra Healthcare REIT stock in a transaction dated Tuesday, May 20th. The shares were sold at an average price of $18.22, for a total transaction of $200,420.00. Following the completion of the transaction, the director directly owned 64,725 shares of the company’s stock, valued at $1,179,289.50. This trade represents a 14.53% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. 1.20% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

A number of brokerages have issued reports on SBRA. Truist Financial raised their price target on shares of Sabra Healthcare REIT from $17.00 to $18.00 and gave the stock a “hold” rating in a report on Tuesday, March 18th. Scotiabank raised their price target on shares of Sabra Healthcare REIT from $19.00 to $20.00 and gave the stock a “sector perform” rating in a report on Monday, June 23rd. Three equities research analysts have rated the stock with a hold rating, three have given a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $19.67.

Sabra Healthcare REIT Trading Up 0.5%

NASDAQ:SBRA opened at $18.46 on Friday. The company has a 50-day moving average price of $18.00 and a 200-day moving average price of $17.37. Sabra Healthcare REIT, Inc. has a 12 month low of $15.60 and a 12 month high of $20.03. The company has a current ratio of 4.22, a quick ratio of 4.22 and a debt-to-equity ratio of 0.89. The stock has a market cap of $4.39 billion, a price-to-earnings ratio of 31.29, a P/E/G ratio of 1.52 and a beta of 0.85.

Sabra Healthcare REIT (NASDAQ:SBRA) last posted its earnings results on Monday, May 5th. The real estate investment trust reported $0.37 EPS for the quarter, topping the consensus estimate of $0.36 by $0.01. Sabra Healthcare REIT had a net margin of 19.55% and a return on equity of 5.14%. The firm had revenue of $183.54 million during the quarter, compared to analysts’ expectations of $180.23 million. During the same period last year, the company posted $0.35 EPS. The company’s quarterly revenue was up 10.1% compared to the same quarter last year. Equities analysts predict that Sabra Healthcare REIT, Inc. will post 1.45 EPS for the current year.

Sabra Healthcare REIT Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, May 30th. Investors of record on Friday, May 16th were given a dividend of $0.30 per share. The ex-dividend date was Friday, May 16th. This represents a $1.20 dividend on an annualized basis and a yield of 6.50%. Sabra Healthcare REIT’s dividend payout ratio (DPR) is currently 203.39%.

About Sabra Healthcare REIT

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.